High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial

Not available.

Saved in:
Bibliographic Details
Main Authors: Margot S. F. Roeten, Johan van Meerloo, Suzanne N. van Dijk, Zinia Kwidama, Gaye Jenkins, David T. Teachey, Meenakshi Devidas, Mignon L. Loh, Gertjan J. L. Kaspers, Sonja Zweegman, Gerrit Jansen, Terzah M. Horton, Jacqueline Cloos
Format: Article
Language:English
Published: Ferrata Storti Foundation 2025-01-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/11922
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832577678480244736
author Margot S. F. Roeten
Johan van Meerloo
Suzanne N. van Dijk
Zinia Kwidama
Gaye Jenkins
David T. Teachey
Meenakshi Devidas
Mignon L. Loh
Gertjan J. L. Kaspers
Sonja Zweegman
Gerrit Jansen
Terzah M. Horton
Jacqueline Cloos
author_facet Margot S. F. Roeten
Johan van Meerloo
Suzanne N. van Dijk
Zinia Kwidama
Gaye Jenkins
David T. Teachey
Meenakshi Devidas
Mignon L. Loh
Gertjan J. L. Kaspers
Sonja Zweegman
Gerrit Jansen
Terzah M. Horton
Jacqueline Cloos
author_sort Margot S. F. Roeten
collection DOAJ
description Not available.
format Article
id doaj-art-790dae2aa02c4dd79da29d72a2a02093
institution Kabale University
issn 0390-6078
1592-8721
language English
publishDate 2025-01-01
publisher Ferrata Storti Foundation
record_format Article
series Haematologica
spelling doaj-art-790dae2aa02c4dd79da29d72a2a020932025-01-30T19:44:24ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-01-01999110.3324/haematol.2024.286171High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trialMargot S. F. Roeten0Johan van Meerloo1Suzanne N. van Dijk2Zinia Kwidama3Gaye Jenkins4David T. Teachey5Meenakshi Devidas6Mignon L. Loh7Gertjan J. L. Kaspers8Sonja Zweegman9Gerrit Jansen10Terzah M. Horton11Jacqueline Cloos12Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit Amsterdam, AmsterdamDepartment of Hematology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit Amsterdam, AmsterdamDepartment of Hematology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit Amsterdam, AmsterdamDepartment of Hematology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit Amsterdam, AmsterdamTexas Children's Hospital, Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine and Dan L. Duncan Cancer Center, Houston, TXDepartment of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and The Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PADepartment of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TNDivision of Hematology, Oncology, BMT, and Cellular Therapies, Seattle Children’s Hospital, Seattle, WAPrincess Máxima Center of Pediatric Oncology, Utrecht, The Netherlands; Emma Children’s Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, AmsterdamDepartment of Hematology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit Amsterdam, AmsterdamAmsterdam Rheumatology and Immunology Center, Cancer Center Amsterdam, Amsterdam UMC, location Vrije Universiteit, AmsterdamTexas Children's Hospital, Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine and Dan L. Duncan Cancer Center, Houston, TXDepartment of Hematology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam Not available. https://haematologica.org/article/view/11922
spellingShingle Margot S. F. Roeten
Johan van Meerloo
Suzanne N. van Dijk
Zinia Kwidama
Gaye Jenkins
David T. Teachey
Meenakshi Devidas
Mignon L. Loh
Gertjan J. L. Kaspers
Sonja Zweegman
Gerrit Jansen
Terzah M. Horton
Jacqueline Cloos
High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial
Haematologica
title High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial
title_full High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial
title_fullStr High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial
title_full_unstemmed High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial
title_short High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial
title_sort high immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib containing chemotherapy update from the children s oncology group aall1231 trial
url https://haematologica.org/article/view/11922
work_keys_str_mv AT margotsfroeten highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial
AT johanvanmeerloo highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial
AT suzannenvandijk highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial
AT ziniakwidama highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial
AT gayejenkins highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial
AT davidtteachey highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial
AT meenakshidevidas highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial
AT mignonlloh highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial
AT gertjanjlkaspers highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial
AT sonjazweegman highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial
AT gerritjansen highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial
AT terzahmhorton highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial
AT jacquelinecloos highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial